--- a
+++ b/clusters/9knumclustersv2/clust_1097.txt
@@ -0,0 +1,38 @@
+Evidence of progressive multifocal leukoencephalopathy (PML) identified on the pretreatment magnetic resonance imaging (MRI)
+History of progressive multifocal leukoencephalopathy (PML)
+Patients with a known John Cunningham (JC) virus infection and/or progressive multifocal leukoencephalopathy (PML) are not eligible
+History of autoimmune disease or of confirmed progressive multifocal leukoencephalopathy
+History of progressive multifocal leukoencephalopathy (PML)
+History of progressive multifocal leukoencephalopathy (PML)
+Patients must not have known John Cunningham (JC) virus infection and/or progressive multifocal leukoencephalopathy (PML)
+History of progressive multifocal leukoencephalopathy (PML).
+History of progressive multifocal leukoencephalopathy (PML)
+Participants with known history of pancreatitis or progressive multifocal leukoencephalopathy (PML)
+History of progressive multifocal leukoencephalopathy (PML)
+Present or history of progressive multifocal leukoencephalopathy (PML)
+Participants with a history of progressive multifocal leukoencephalopathy
+History of progressive multifocal leukoencephalopathy
+History of or current diagnosis of progressive multifocal leukoencephalopathy (PML)
+Known human immunodeficiency virus (HIV) or hepatitis B positivity or prior progressive multifocal leukoencephalopathy (PML)
+History of progressive multifocal leukoencephalopathy (PML)
+History of progressive multifocal leukoencephalopathy
+History of progressive multifocal leukoencephalopathy (PML)
+History of progressive multifocal leukoencephalopathy (PML)
+Has active cerebral/meningeal disease, active cytomegalovirus (CMV) colitis, or signs and symptoms of progressive multifocal leukoencephalopathy (PML) or any history of PML.
+Participants with history of confirmed progressive multifocal leukoencephalopathy (PML)
+History of progressive multifocal leukoencephalopathy
+History of progressive multifocal leukoencephalopathy
+Present or history of progressive multifocal leukoencephalopathy (PML)
+History of progressive multifocal leukoencephalopathy
+Cerebral/meningeal disease, including signs and symptoms of progressive multifocal leukoencephalopathy (PML)
+Participants with a history of confirmed progressive multifocal leukoencephalopathy (PML)
+History of progressive multifocal leukoencephalopathy (PML)
+Known active cerebral/meningeal disease, including signs or symptoms of progressive multifocal leukoencephalopathy (PML);
+Participants with a history of confirmed progressive multifocal leukoencephalopathy (PML)
+History of progressive multifocal leukoencephalopathy (PML).
+In subjects with AITL, evidence of meningeal or cerebral disease or a history of progressive multifocal leukoencephalopathy
+History of progressive multifocal leukoencephalopathy (PML)
+Known active cerebral/meningeal disease, including signs or symptoms of progressive multifocal leukoencephalopathy (PML) or any history of PML
+Known cerebral/meningeal disease, including history of progressive multifocal leukoencephalopathy
+Patients with history of confirmed progressive multifocal leukoencephalopathy
+Known John Cunningham (JC) virus infection and/or progressive multifocal leukoencephalopathy (PML)